Kiniksa Pharmaceuticals L... (KNSA)
NASDAQ: KNSA
· Real-Time Price · USD
27.79
0.82 (3.04%)
At close: May 01, 2025, 3:59 PM
27.85
0.22%
After-hours: May 01, 2025, 07:17 PM EDT
Kiniksa Pharmaceuticals Revenue
Kiniksa Pharmaceuticals reported an annual revenue of $423.24M, reflecting a 56.6% growth. For the quarter ending March 31, 2025, Kiniksa Pharmaceuticals generated $137.78M in revenue.
Revenue (ttm)
$423.24M
Revenue Growth
56.6%
Price / Sales Ratio
3.34
Revenue / Employee
$1.34M
Employees
315
Market Cap
2.03B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 423.24M | +56.60% |
Dec 31, 2023 | 270.26M | +22.74% |
Dec 31, 2022 | 220.18M | +471.24% |
Dec 31, 2021 | 38.54M | +Infinity% |
Dec 31, 2020 | 0 | n/a |